Cargando…

Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry

Necrostatins have been shown to retard necroptosis, a programmed necrotic-like cell death, which has been shown to underlie pathophysiology of various diseases. Nec-1s, a novel highly effective necrostatin, overcomes some drawbacks of former necrostatin analogues. The determination of Nec-1s in biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikuš, Peter, Pecher, Daniel, Rauová, Drahomíra, Horváth, Csaba, Szobi, Adrián, Adameová, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222636/
https://www.ncbi.nlm.nih.gov/pubmed/30081531
http://dx.doi.org/10.3390/molecules23081946
_version_ 1783369252531601408
author Mikuš, Peter
Pecher, Daniel
Rauová, Drahomíra
Horváth, Csaba
Szobi, Adrián
Adameová, Adriana
author_facet Mikuš, Peter
Pecher, Daniel
Rauová, Drahomíra
Horváth, Csaba
Szobi, Adrián
Adameová, Adriana
author_sort Mikuš, Peter
collection PubMed
description Necrostatins have been shown to retard necroptosis, a programmed necrotic-like cell death, which has been shown to underlie pathophysiology of various diseases. Nec-1s, a novel highly effective necrostatin, overcomes some drawbacks of former necrostatin analogues. The determination of Nec-1s in biological system, however, has not been carried out so far. Therefore, this study was undertaken to optimize and validate the HPLC-DAD-Q-TOF method for the assessment of Nec-1s levels in the plasma what is the necessity for designing its proper dosing regimen for in vivo studies. Benefits of the proposed analytical protocol include: (i) simple sample preparation (precipitation of plasma proteins, evaporation of acetonitrile, reconstitution in mobile phase), (ii) fast, selective and sensitive analysis due to a highly orthogonal LC-MS system providing less than 8 min analysis time, (iii) detection of Nec-1s without any matrix interferences, and quantitation of very low concentration levels of Nec-1s (LLOQ ~ 20 ng/mL), (iv) high reliability of Nec-1s determination with precision and accuracy values meeting the FDA criteria for biomedical analysis. The proposed analytical protocol is suitable for routine use in relevant biological studies, and, in this work, it was successfully applied for monitoring of Nec-1s plasma levels in rats providing reproducible and consistent results. Based on pharmacokinetic features, which can also be assessed due to the results of this study, there will be efforts to perform both acute and chronic in vivo studies and potential clinical safety studies first.
format Online
Article
Text
id pubmed-6222636
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62226362018-11-13 Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry Mikuš, Peter Pecher, Daniel Rauová, Drahomíra Horváth, Csaba Szobi, Adrián Adameová, Adriana Molecules Article Necrostatins have been shown to retard necroptosis, a programmed necrotic-like cell death, which has been shown to underlie pathophysiology of various diseases. Nec-1s, a novel highly effective necrostatin, overcomes some drawbacks of former necrostatin analogues. The determination of Nec-1s in biological system, however, has not been carried out so far. Therefore, this study was undertaken to optimize and validate the HPLC-DAD-Q-TOF method for the assessment of Nec-1s levels in the plasma what is the necessity for designing its proper dosing regimen for in vivo studies. Benefits of the proposed analytical protocol include: (i) simple sample preparation (precipitation of plasma proteins, evaporation of acetonitrile, reconstitution in mobile phase), (ii) fast, selective and sensitive analysis due to a highly orthogonal LC-MS system providing less than 8 min analysis time, (iii) detection of Nec-1s without any matrix interferences, and quantitation of very low concentration levels of Nec-1s (LLOQ ~ 20 ng/mL), (iv) high reliability of Nec-1s determination with precision and accuracy values meeting the FDA criteria for biomedical analysis. The proposed analytical protocol is suitable for routine use in relevant biological studies, and, in this work, it was successfully applied for monitoring of Nec-1s plasma levels in rats providing reproducible and consistent results. Based on pharmacokinetic features, which can also be assessed due to the results of this study, there will be efforts to perform both acute and chronic in vivo studies and potential clinical safety studies first. MDPI 2018-08-03 /pmc/articles/PMC6222636/ /pubmed/30081531 http://dx.doi.org/10.3390/molecules23081946 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mikuš, Peter
Pecher, Daniel
Rauová, Drahomíra
Horváth, Csaba
Szobi, Adrián
Adameová, Adriana
Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry
title Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry
title_full Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry
title_fullStr Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry
title_full_unstemmed Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry
title_short Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry
title_sort determination of novel highly effective necrostatin nec-1s in rat plasma by high performance liquid chromatography hyphenated with quadrupole-time-of-flight mass spectrometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222636/
https://www.ncbi.nlm.nih.gov/pubmed/30081531
http://dx.doi.org/10.3390/molecules23081946
work_keys_str_mv AT mikuspeter determinationofnovelhighlyeffectivenecrostatinnec1sinratplasmabyhighperformanceliquidchromatographyhyphenatedwithquadrupoletimeofflightmassspectrometry
AT pecherdaniel determinationofnovelhighlyeffectivenecrostatinnec1sinratplasmabyhighperformanceliquidchromatographyhyphenatedwithquadrupoletimeofflightmassspectrometry
AT rauovadrahomira determinationofnovelhighlyeffectivenecrostatinnec1sinratplasmabyhighperformanceliquidchromatographyhyphenatedwithquadrupoletimeofflightmassspectrometry
AT horvathcsaba determinationofnovelhighlyeffectivenecrostatinnec1sinratplasmabyhighperformanceliquidchromatographyhyphenatedwithquadrupoletimeofflightmassspectrometry
AT szobiadrian determinationofnovelhighlyeffectivenecrostatinnec1sinratplasmabyhighperformanceliquidchromatographyhyphenatedwithquadrupoletimeofflightmassspectrometry
AT adameovaadriana determinationofnovelhighlyeffectivenecrostatinnec1sinratplasmabyhighperformanceliquidchromatographyhyphenatedwithquadrupoletimeofflightmassspectrometry